K+S Group, Kassel, this week reminded the wider industry of its important contribution to the production of active ingredients for the pharmaceutical industry. It said its specialties in this sector comprise a wide range of applications “not only enriching our lives on a daily basis, but also being vital.”
The Biontech/Pfizer corona vaccine ComirnatyR is only applicable with the addition of high-purity sodium chloride solution, K+S said, adding that it is one of the largest manufacturers of the pharmaceutical-grade sodium chloride required for this purpose.
“Prior to injection, the Biontech/Pfizer corona vaccine must first be diluted with 1.8 ml NaCl per dose before it can be administered,” the company said. “The high-purity sodium chloride contained in the saline solution is the mode of transportation for the vaccine enabling its absorption by the human organism.”
K+S is the world’s largest producer of pharmaceutical salt. In Germany, the company produces several 10,000 mt of high-purity sodium chloride annually at the Borth salt plant in the Wesel district of North Rhine-Westphalia. High purity sodium chloride is not only used as an infusion solution in hospitals, but also in dialysis and for the production of pharmaceuticals.